Intraosseous Growth of Human Prostate Cancer in Implanted Adult Human Bone: Relationship of Prostate Cancer Cell to Osteoclasts in Osteoblastic Metastatic Lesions

Prostate

Volumn 58, Issue 4, 2004, Pages 406-413

  Yonou, Hiroyuki ^a,b   Ochiai, Atsushi ^b   Goya, Masato ^b   Kanomata, Naoki ^b   Hokama, Sanehiro ^a   Morozumi, Makoto ^a   Sugaya, Kimio ^a   Hatano, Tadashi ^a   Ogawa, Yoshihide ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Adult human bone; Osteoblastic bone metastasis; Osteoclast; Prostate cancer

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; BONE METASTASIS; BONE REMODELING; CANCER GRAFT; CANCER GROWTH; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROSTATE CANCER; SCID MOUSE;

ANIMALS; BONE MARROW; BONE NEOPLASMS; CELL COUNT; HUMANS; MALE; MICE; MICE, INBRED NOD; MICE, SCID; OSTEOBLASTS; OSTEOCLASTS; PROSTATIC NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS;

EID: 1542317670     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.10349     Document Type: Article

References (29)

1. Abrams HL, Spiro R, Goldstein N. Metastases in carcinoma: Analysis of 1000 autopsied cases. Cancer 1950;3:74-85.
2. Linehan WM, Long JP, Steeg PS, Gnarra JR. Metastatic models and molecular genetics of prostate cancer. J Natl Cancer Inst 1992;84:914-915.
3. Clarke NW, McClure J, George NJ. Disodium pamidronate identifies differential osteoclastic bone resorption in metastatic prostate cancer. Br J Urol 1992;69:64-70.
4. Charhon SA, Chapuy MC, Delvin EE, Valentin-Opran A, Edouard CM, Meunier PJ. Histomorphometric analysis of sclerotic bone metastases from prostatic carcinoma special reference to osteomalacia. Cancer 1983;51:918-924.
5. Urwin GH, Percival RC, Harris S, Beneton MN, Williams JL, Kanis JA. Generalised increase in bone resorption in carcinoma of the prostate. Br J Urol 1985;57:721-723.
6. Percival RC, Urwin GH, Harris S, Yates AJ, Williams JL, Beneton M, Kanis JA. Biochemical and histological evidence that carcinoma of the prostate is associated with increased bone resorption. Eur J Surg Oncol 1987;13:41-49.
7. Pecherstorfer M, Zimmer-Roth I, Schilling T, Woitge HW, Schmidt H, Baumgartner G, Thiebaud D, Ludwig H, Seibel MJ. The diagnostic value of urinary pyridinium cross-links of collagen, serum total alkaline phosphatase, and urinary calcium excretion in neoplastic bone disease. J Clin Endocrinol Metab 1995;80:97-103.
8. Garnero P, Buchs N, Zekri J, Rizzoli R, Coleman RE, Delmas PD. Markers of bone turnover for the management of patients with bone metastases from prostate cancer. Br J Cancer 2000;82:858-864.
9. Fontana A, Delmas PD. Markers of bone turnover in bone metastases. Cancer 2000;88:2952-2960.
10. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, Murphy GP. LNCaP model of human prostatic carcinoma. Cancer Res 1983;43:1809-1818.
11. Yonou H, Yokose T, Kamijo T, Kanomata N, Hasebe T, Nagai K, Hatano T, Ogawa Y, Ochiai A. Establishment of a novel species- and tissue-specific metastasis model of human prostate cancer in humanized non-obese diabetic/ severe combined immunodeficient mice engrafted with human adult lung and bone. Cancer Res 2001;61:2177-2182.
12. Kyoizumi S, Baum CM, Kaneshima H, McCune JM, Yee EJ, Namikawa R. Implantation and maintenance of functional human bone marrow in SCID-hu mice. Blood 1992;79:1704-1711.
13. Yoshiki S, Ueno T, Akita T, Yamanouchi M. Improved procedure for histological identification of osteoid matrix in decalcified bone. Stain Technol 1983;58:85-89.
14. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-580.
15. Cole AA, Walters LM. Tartrate-resistant acid phosphatase in bone cartilage following decalcification and cold-embedding in plastic. J Histochem Cytochem 1987;35:203-206.
16. Goltzman D. Mechanisms of the development of osteoblastic metastases. Cancer 1997;80:1581-1587.
17. Yonou H, Kanomata N, Goya M, Kamijo T, Yokose T, Hasebe T, Nagai K, Hatano T, Ogawa Y, Ochiai A. Osteoprotegerin/osteoclastogenesis inhibitory factor decreases human prostate cancer burden in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice. Cancer Res 2003;63:2096-2102.
18. Yoneda T. Cellular and molecular mechanisms of breast and prostate cancer metastasis to bone. Eur J Cancer 1998;34:240-245.
19. Watt KW, Lee PJ, M'Timkulu T, Chan WP, Loor R. Human prostate-specific antigen: Structural and functional similarity with serine proteases. Proc Natl Acad Sci USA 1986;83:3166-3170.
20. Lilja H. Structure, function, and regulation of the enzyme activity of prostate-specific antigen. World J Urol 1993;11:188-191.
21. Cramer SD, Chen Z, Peehl DM. Prostate specific antigen cleaves parathyroid hormone-related protein in the PTH-like domain: Inactivation of PTHrP-stimulated cAMP accumulation in mouse osteoblasts. J Urol 1996;156:526-531.
22. Iwamura M, Hellman J, Cockett AT, Lilja H, Gershagen S. Alteration of the hormonal bioactivity of parathyroid hormone-related protein (PTHrP) as a result of limited proteolysis by prostate-specific antigen. Urology 1996;48:317-325.
23. Killian CS, Corral DA, Kawinski E, Constantine RI. Mitogenic response of osteoblast cells to prostate-specific antigen suggests an activation of latent TGF-beta and a proteolytic modulation of cell adhesion receptors. Biochem Biophys Res Commun 1993;192:940-947.
24. Yonou H, Aoyagi Y, Kanomata N, Kamijo T, Oda T, Yokose T, Hasebe T, Nagai K, Hatano T, Ogawa Y, Ochiai A. Prostate-specific antigen induces osteoplastic change by an autonomous mechanism. Biochem Biophys Res Commun 2001;289:1082-1087.
25. Sasaki A, Williams PJ, Mundy GR, Yoneda T. Osteolysis and tumor growth are enhanced in sites of increased bone turnover in vivo. J Bone Miner Res 1994;9:S294.
26. Hauschka PV, Mavrakos AE, Iafrati MD, Doleman SE, Klagsbrun M. Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose. J Biol Chem 1986;261:12665-12674.
27. Pfeilschifter J, Mundy GR. Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones. Proc Natl Acad Sci USA 1987;84:2024-2028.
28. Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1889;1:571-573.
29. Mundy GR, Yoneda T. Facilitation and suppression of bone metastasis. Clin Orthop 1995;312:34-44.